Covid-19, Vaccination and the future of the pandemic, a Public Health perspective
DOI:
https://doi.org/10.20453/rmh.v33i1.4162References
Kumar A, Blum J, Thanh Le T, Havelange N, Magini D, Yoon IK. The mRNA vaccine development landscape for infectious diseases. Nat Rev Drug Discov. 2022 Feb 11. doi: 10.1038/d41573-022- 00035-z.
United Nations Department of Economic and Social Affairs. No one is safe, until everyone is. 2020 Jul 22; (Citado el 18 de febrero de 2022) https://www.un.org/en/desa/%E2%80%9Cno-one-safe- until-everyone-%E2%80%9D
Murray CJL. Covid 19 will continue but the end of the Pandemic is near. Chris Murray. Lancet. 2022 Jan 29; 399(10323):417-419. doi: 10.1016/S0140-6736(22)00100-3.
Barry JM. El fin de la pandemia no está cerca, aprendamos de la pandemia de 1918. New York Times. 2022 Feb 4;(Citado el 18 de febrero de 2022) Disponible en: https://www.nytimes. com/es/2022/02/04/espanol/opinion/covid-fin-pandemia-omicron. html
La OMS considera prematuro declarar una victoria frente al Covid-19, Diario Gestión. Lima, Perú. 2022 Feb 1; (Citado el 18 de febrero de 2022) Disponible en: https://gestion.pe/mundo/ coronavirus-la-oms-considera-prematuro-declarar-una-victoria- frente-al-covid-19-rmmn-noticia/
Crist C. Poll: 27% of Americans Believe Worst of Pandemic Yet to Come. WebMD. 2022 Feb 07; (Citado el 18 de febrero de 2022) Disponible en: https://www.webmd.com/lung/news/20220207/poll- worst-pandemic-yet-to-come
Efectividad de refuerzo de vacuna antiCovid-19 disminuye tras cuatro meses, señala estudio. Diario Gestión Lima, Perú. 2022 Feb 12; (Citado el 18 de febrero de 2022) Disponible en: https://gestión. pe/mundo/efectividad-de-refuerzo-de-vacuna-anticovid- disminuye-tras-cuatro-meses-senala-estudio-noticia/
Pfizer quiere vender USD $54 mil millones en vacunas y píldoras anticovid. Diario Gestión Lima, Perú. 2022 Feb 10; Disponible en: https://gestion.pe/economia/empresas/pfizer-quiere-vender- usd-54000-millones-en-vacunas-y-pildoras-anticovid-en-2022- noticia/?ref=gesr
Kennedy M, Sweet K. US death toll from COVID-19 hits 900,000, sped by omicron. AP news. 2022 Feb 4; (Citado el 18 de febrero de 2022) Disponible en: https://apnews.com/article/us-hits-covid- deaths-milestone-coronavirus-omicron-76dc452fb7263612529e0 9eb23bc0f24?utm_medium=AP&utm_campaign=Social Flow&utm_source=Twitter
Covid-19 en el Perú: Ya estamos en fase de descenso de la 3ª ola, confirma director del CDC. Entrevista. Diario El Comercio Lima, Perú. 7 de febrero 2022. https://elcomercio.pe/lima/sucesos/ covid-19-en-peru-ya-estamos-en-fase-de-descenso-de-la-tercera- ola-confirma-director-de-cdc-video-cesar-munayco-coronavirus- minsa-rmmn-noticia/
Editorial Board. Peru deserves a fresh political startFinancial Times. 2022 Feb 14; https://www.ft.com/content/6bf19350-4882- 4d2f-905b-3230c1b068b0
COVID-19 National Preparedness Collaborators. Pandemic preparedness and Covid-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries from Jan 1, 2020 to Sept 30, 2021. Lancet 2022 Feb 1: S0140-6736(22)00172-6. doi: 10.1016/S0140- 6736(22)00172-6.
Bernstein AS, Ando AW, Loch-Temzelides T, et al. The costs and benefit of primary prevention of zoonotic pandemics. Sci Adv. 2022 Feb 4; 8(5): eabl4183. doi: 10.1126/sciadv.abl4183.
Downloads
Published
How to Cite
Issue
Section
License
Authors assign their rights to the RMH so that may disseminate the article through the means at their disposal. The journal will provide forms of affidavit of authorship and authorization for the publication of the article, which shall be submitted with the manuscript. Authors retain the right to share, copy, distribute, perform and publicly communicate their article, or part of it, mentioning the original publication in the journal.
